Dr. Michael Robert Wilson, MD

Dr. Wilson practices at UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco, California, part of University of California Health.

Dr. Wilson's NPI, 1134324791, was assigned on June 15, 2007. Dr. Wilson graduated from UCSF School of Medicine in 2007. Dr. Wilson holds California license A125397.

Dr. Wilson's primary practice is UCSF Helen Diller Medical Center at Parnassus Heights, at 505 Parnassus Ave, Box 0296, San Francisco, CA 94143 in San Francisco County. The practice phone is (415) 353-2733.

Dr. Wilson's primary practice is UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco, California, part of University of California Health. The medical group on file is UCSF Pediatrics. Dmand AI also links Dr. Wilson to 3 more group practices and clinics and 3 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Wilson practices, 4 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Wilson's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Wilson is board certified in neurology by the American Board of Psychiatry and Neurology. Dmand AI has Dr. Wilson's licenses on file in 2 states: California and Massachusetts.

Dmand AI lists encephalopathy, mobility impairment, multiple sclerosis and seizures among the conditions Dr. Wilson treats.

CMS data shows 117 Medicare services from Dr. Wilson across 4 procedure codes in 2024, for 76 Medicare patients. Medicare paid $8,249 for them.

CMS counts 76 Medicare patients who saw Dr. Wilson in 2024. The largest group is 75 to 84, with 27 patients. 75% of them have high blood pressure, and 70% have high cholesterol. 61% are also on Medicaid. Their average risk score is 2.20, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Wilson's median patient age at 66, with 42% women.

In 2024, Dr. Wilson wrote 221 Medicare Part D claims for 41 patients. 81% of them were for generic drugs. CMS names the drug for 82 of them, across 4 drugs with 11 or more claims each, at $90,732 in total drug cost. In 2023, CMS named 87 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 97 out of 100 for Dr. Wilson for performance year 2024, reported as part of a group. Dr. Wilson accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Wilson as offering telehealth.

Dmand AI links 119 papers to Dr. Wilson, published from 2005 to 2025. 2023 was the busiest year, with 17. The most frequent topics are Autoantibodies, Multiple Sclerosis and COVID-19. Dr. Wilson has published most often in Neurol Neuroimmunol Neuroinflamm. Dr. Wilson's most frequent co-authors are Samuel J. Pleasure, MD, Jeffrey Marc Gelfand, MD and Prashanth Sriram Ramachandran, MBBS.

CMS Open Payments shows 6 general payments to Dr. Wilson from 5 drug and device companies from 2017 to 2025. Consulting fees make up the largest share, 99% of the total. Merck Sharp & Dohme Corporation paid the most, $3,021. It also lists 3 research payments totaling $2,435 from 2020 to 2023.

Dmand AI lists 6 awards for Dr. Wilson, most recently Elected Member in 2025.

Dr. Wilson graduated from UCSF School of Medicine in 2007. Dr. Wilson is a member of AOA, AAN and American Neurological Association.

Dr. Wilson is in network with 10 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.